Environmental epidemiology: challenges and opportunities. by Pekkanen, J & Pearce, N
Environmental Health Perspectives • VOLUME 109 | NUMBER 1 | January 2001 1
Environmental Epidemiology: Challenges and Opportunities
Juha Pekkanen1 and Neil Pearce2
1Unit of Environmental Epidemiology, National Public Health Institute, Kuopio, Finland; 2Center for Public Health Research, Massey
University, Wellington Campus, Wellington, New Zealand
.Modern “risk factor” epidemiology may be
facing its limits (1). Epidemiology often
appears to be struggling with ever-larger
problems with correlated exposures and small
relative risks (2). This crisis has produced, for
some, a stronger emphasis on molecular epi-
demiology (3). Other authors have argued
that the best solution is for epidemiology to
focus again on population and to reintegrate
itself into public health (4,5). This “ecoepi-
demiology” approach involves conducting
research at all possible levels of analysis, but
the population level is fundamental in that it
deﬁnes the key public health problems to be
addressed and the population context in
which these problems occur (6,7).
These issues have been debated exten-
sively in the general epidemiology litera-
ture, but there has been less consideration
of how these debates relate specifically to
the current practice of environmental epi-
demiology. In fact, environmental epidemi-
ology has several unique features that make
this debate especially pertinent to it. These
include the very large number of exposures,
which occur in low concentrations in com-
plex mixtures and often do not differ
greatly among individuals within one area.
Therefore, the relative risks are usually very
low. Furthermore, the most important
long-term environmental health problems
are probably the indirect and long-term
effects on local and global ecosystems,
which are only beginning to receive atten-
tion from environmental epidemiologists
(8). In fact, most previous discussions (9)
have not considered the ecosystem level,
which is unique to environmental epidemi-
ology. Besides the scientiﬁc issues, consider-
ation of the population and ecosystem
context is important in risk management
decisions (10). Prevention of involuntary
population exposures such as outdoor air
pollution or environmental tobacco smoke
involve scientific, practical, and ethical
issues quite different from those involved in
the prevention of “lifestyle” factors such as
active tobacco smoking or diet.
Perhaps the most pertinent characteristic
of environmental epidemiology is that, by
deﬁnition, it focuses on the environment in
which individuals live rather than on their
personal characteristics or lifestyles. During
the past centuries, environmental health and
environmental epidemiology have achieved
remarkable health gains by focusing on
reducing the population’s exposure to conta-
minants in air, water, and soil. However, in
the last decades, this focus has been changing
to match developments in epidemiology and
molecular biology. With increasing emphasis
on individual exposures and susceptibility
and on mechanisms, environmental epidemi-
ologists are in danger of losing their popula-
tion perspective of disease causation and
prevention.
Environmental health problems can be
approached on four different levels: the mol-
ecular, the individual, the population, or the
ecosystem level (5,11). In this paper we ﬁrst
list briefly the main challenges to environ-
mental epidemiology today and then discuss
the advantages and disadvantages of these
different “levels of approach” in addressing
the challenges of environmental epidemiol-
ogy. We conclude that the main environ-
mental health problems need to be defined
at the population and ecosystem levels,
instead of allowing the available research
methodology to deﬁne the problems that are
considered most appropriate for study.
Research and development of new research
methods is needed at all levels, from the
molecular to the ecosystem, but it is crucially
important to choose the most appropriate
level, or levels, of research for a particular
environmental problem. Developing further
our research methods and combining evi-
dence from these various levels of research
are the keys to addressing the current chal-
lenges to environmental health, and also
provide significant opportunities for the
development of the ﬁeld.
Challenges
As noted above, environmental epidemiology
focuses on the health effects of environmen-
tal factors that are outside the immediate
control of the individual (2). In industrialized
countries, environmental epidemiologists
often must assess a large number of low-level
intercorrelated exposures, which often occur
in complex mixtures. In that respect environ-
mental epidemiology is similar to nutritional
epidemiology, except that environmental
exposures usually are involuntary and do not
differ signiﬁcantly among individuals within
one area. A typical example is contamination
of community drinking water supplies,
which affects all residents more or less
equally.
The relative increases in disease risks due
to environmental exposures usually are very
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201-265. low, typically below 1.5 (12). In addition,
most chronic diseases of interest in environ-
mental epidemiology, have other, much
stronger determinants than the environmen-
tal exposure. This leads to problems with
controlling for confounding. Therefore,
research ﬁndings often have been inconclu-
sive. This is especially true for several new
areas of research, such as electromagnetic
ﬁelds and cancer, but is true even for several
classical environmental health problems,
such as passive smoking and radon. Thus,
the future of environmental epidemiology
often is seen as primarily involving even
more research on these same exposures,
using more powerful research methods (12).
Many of the problems of environmental
epidemiology become especially severe dur-
ing local field investigations in response to
acute public health problems, such as a clus-
ter of cancer in a neighborhood or around a
point source (13). In this situation, the level
of exposure is often low and may have hap-
pened in the distant past. Often there is no
clear hypothesis, the small number of resi-
dents gives sufficient power to detect only
relative risks that are unrealistically high in
the environmental setting, or the latency
period may be insufficient. Case–control
studies done in this situation, where the out-
come is a chronic disease such as cancer,
usually have been disappointing (14) because
it is rarely possible to reconstruct personal
exposures accurately. Furthermore, environ-
mental epidemiologists may be unprepared
to address other health outcomes and issues
of public concern, such as psychological
effects, aesthetic values, social disruption, or
effects on property values which may be the
main concern of the public (14,15). 
The large number of environmental
exposures means that environmental epi-
demiology, more than many other fields of
epidemiology, needs to prioritize the issues
to be studied. The current emphasis on mol-
ecular epidemiology means that a hypothesis
may be chosen for study simply because a
new methodology has become available,
rather than because the hypothesis is impor-
tant for science or public health (16). Such
an approach can lead to the neglect of other,
potentially much greater public health prob-
lems, such as the long-term effects of envi-
ronmental decisions on local and global
ecosystems (17).
Ultimately, the survival of the human
race depends on the survival of the global
ecosystem, the atmosphere, arable land,
ocean ﬁsheries, freshwater supplies, and bio-
diversity (11). These systems are increasingly
taxed by overconsumption, overpopulation,
and wasteful technologies. The best-known
examples are the depletion of ozone in the
upper atmosphere and climatic warming.
Ozone protects the earth from excessive
ultraviolet (UV) radiation, which increases
the risk of skin cancer and cataracts.
Climatic warming may be associated with a
large variety of effects, such as an increased
number of deaths from heat waves and other
weather extremes, spread of infectious dis-
eases, declining crops, and major societal dis-
ruption from loss of habitable land through
ﬂooding (17). To increase understanding of
the potential health consequences of these
changes, environmental epidemiologists
must develop new methods of study and
new interdisciplinary collaborations.
Opportunities
We consider the above challenges to envi-
ronmental epidemiology in light of recent
debates about the future of epidemiology
generally, and particularly the importance 
of identifying the appropriate “level of
approach” in epidemiologic research. We
consider these issues by discussing, in turn,
each of the four possible levels of approach. 
As noted above, environmental health
problems can basically be approached at four
different levels, the molecular, the individ-
ual, the population, or the ecosystem level
(5,11). Because epidemiologic research
always involves population and most studies
involve measurements at a variety of levels,
these divisions are arbitrary and there are no
strict lines of demarcation separating the
different levels of study (7). Also other divi-
sions could be used, e.g., immediate versus
long-term effects (18). Nevertheless, most
researchers focus primarily on one of these
levels of study. 
Below we concentrate on scientiﬁc issues
involving epidemiologic research and risk
assessment, but these issues are also crucially
important in risk management decisions and
interventions. Although all of the various lev-
els of epidemiologic research are important,
the population and ecosystem levels are fun-
damental in that they deﬁne the key public
health problems to be addressed. Studies done
at the different levels have their own advan-
tages and disadvantages, but these are speciﬁc
to the problem that is being addressed. Thus,
it is important to conduct environmental epi-
demiology studies at the appropriate level or
levels for the problem under consideration.
To address the current challenges to environ-
mental health, we must develop methods to
conduct research and combine evidence from
these various levels of research.
Micro-Level
The most basic level of analysis in epidemi-
ologic research has been termed the
“micro-level” (19), and is typified by the
current emphasis on “molecular epidemiol-
ogy.” Traditionally, the existence of risks
from speciﬁc exposures (e.g., tobacco smoke,
air pollution) has been established in indi-
vidual-level and population-level studies,
whereas micro-level studies have been used
subsequently to determine the etiologic
mechanism. However, there is currently a
strong movement to routinely use molecular
markers to assess exposure and individual
susceptibility, and as early markers of out-
come in epidemiologic studies (3). This
reductionist approach may lead to excessive
focus on single substances and characteristics
of individuals, whereas the sources of pollu-
tants, other substances in the mixture, and
characteristics of the exposed population are
easily ignored.
Of course, more accurate and sensitive
measures of exposure, outcome, and suscepti-
bility have the potential to increase the power
of epidemiologic studies by increasing the rel-
ative risks observed, e.g., through the reduc-
tion of nondifferential information bias (3)
and/or confounding. Furthermore, knowl-
edge of the molecular mechanisms underlying
the association between exposure and disease
also enhances the biological plausibility of the
observed association. This could in turn lead
to stronger inferences on causality and
improvements in our ability to undertake tra-
ditional risk assessment. Such studies can also
give feedback to regulatory toxicology on the
plausibility of the extrapolations from the ani-
mal data. This is an important activity
because epidemiologic studies can address
only very few exposures, which means that
most environmental risk assessment will be
based solely on toxicologic studies.
However, because molecular markers are
very expensive, studies using them usually
have very small sample sizes. The power of
the study thus may actually be less than with
conventional questionnaires: Precision may be
reduced, and validity may also be compro-
mised because control of confounding may be
impossible. For example, a recent study com-
pared the types of gene mutations in 12 new-
borns born to mothers with passive tobacco
exposure during pregnancy with 12 nonex-
posed newborn, but in the analyses no other
characteristics of the mothers or newborns
were considered (20). Also, the biomarkers
currently available are often poorly validated
and in many instances inferior to standard
questionnaires (3,16). A typical example is the
association of smoking or occupational expo-
sures with cancer risk: Questionnaires or work
histories give a good estimate of the long-term
cumulative exposure, whereas biomarkers
tend to reﬂect only recent exposure.
Better exposure markers in theory can be
used to attempt to separate the effects of
single chemicals in complex mixtures.
However, in practice the effects of a single
chemical are often impossible to disentangle
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correlated and the exposure that has been
measured may actually stand as a marker for
the whole mixture. Typically, exposures to
single chemicals are measured because a bio-
logical marker is available, and individual
differences in metabolism of speciﬁc chemi-
cals may mean that a biomarker of a speciﬁc
chemical may be a very poor marker of expo-
sure to other chemicals in the mixture,
which may be more etiologically relevant
(16). In such a situation, it may be more
useful to study and regulate the mixture,
e.g., emissions from diesel vehicles, than to
attempt the impossible task of identifying
the individual etiologically relevant con-
stituent, if it exists. 
Furthermore, the limited number of mol-
ecular markers available means that often the
methods available, not the problem at hand,
determine the exposures and outcomes that
will be studied. Most exposures are associated
with multiple outcomes, and an overempha-
sis on a few outcomes that are considered
“most important” may produce invalid expo-
sure standards for other outcomes (21).
Individual Level 
Most of epidemiologic research in the few
past decades has been individual “risk factor”
epidemiology. This approach has had
remarkable successes, such as discovering the
association between smoking and lung can-
cer or discovering the main preventable risk
factors of coronary heart disease. Lately this
approach has come under strong attack.
Some have argued that all the main risk fac-
tors that can be discovered using question-
naires and crude biological markers have
already been found and that we need more
sensitive and specific biomarkers of expo-
sure, susceptibility, and outcome to refine
our knowledge about disease mechanisms
and risks (1). Other authors have argued that
the best way forward is for epidemiology to
regain its focus on population (4,5). 
A focus on individual-level studies and
personal exposures has often created and
reﬂected the assumption that only these most
proximate causes of disease risk are  “real”
causes (18). Therefore, hypotheses are formu-
lated mainly on the individual level, and
interventions tend to focus on individual sus-
ceptibility and personal habits while other
exposures and determinants of exposure are
considered “fixed” and thus not susceptible
to intervention. This approach is problematic
in epidemiology in general (9), but is particu-
larly inappropriate in environmental epi-
demiology because of the involuntary and
widespread nature of many exposures.
In environmental epidemiology the
focus is moving from ecologic studies to
individual-level studies. In the early days of 
environmental epidemiology, much of the
research focused on comparisons of health
between a polluted and a nonpolluted area. 
It is well known that such studies are 
very susceptible to the ecologic fallacy.
Therefore, better individual-level studies with
careful exposure assessment (22) and new,
innovative designs, such as the case–crossover
design (23), clearly have been needed. Such
studies have also significantly advanced the
understanding of environmental health
problems (24).
The ecologic fallacy involves drawing
wrong conclusions on individual-level associ-
ations between exposure and disease from a
study done at the population level. However,
fallacious conclusions can also be drawn at
the individual level from individual-level
studies, if relevant population-level variables
are excluded. Corresponding fallacies exist
also when inferences are drawn at the popu-
lation level (25). Any study focusing on a
single level can fall prey to these fallacies
when information at a different level, which
is crucial to the understanding of the prob-
lem being investigated, is ignored.
As discussed below, an excessive focus on
the individual or the micro-level can lead us
to focus our research and subsequent
interventions on hypotheses generated at
these levels and not on the main environ-
mental health problems. In addition, not all
hypotheses can be studied at the individual
level. A focus on personal exposures may also
ignore long-term, indirect effects. For exam-
ple, to reduce the exposure of the residents
living near the factories, most factories in
Western Europe at ﬁrst were equipped with
long stacks, instead of reducing emissions.
This has contributed to the current prob-
lems with transboundary pollution in
Western Europe and to global climatic
change. 
Population Level
The main environmental health problems
must be deﬁned at the population, or ecosys-
tem, level. In the most simple terms this
means calculating  population-attributable
risks based on the prevalence of exposure and
expected health effects derived from individ-
ual-level studies. This activity is important
especially in environmental health due to the
very large number of low-level exposures, and
is routinely done in risk assessment.
However, reliance only on individual-level
studies neglects the population context in
which these exposures are occurring and also
neglects exposures that are uniform within a
population, but may be important determi-
nants of disease. This has occurred in the epi-
demiology of asthma, where much effort has
been spent on studying the importance of air
pollution and allergens (26); standardized
comparisons among populations are now
revealing major international differences in
the prevalence of asthma that are not
explained by these factors (27), but are more
consistent with the protective role of some
infant infections on the etiology of asthma.
To discover such effects, we need to do com-
parisons among populations as part of a
multilevel research process.
At least three different types of variables
can be separated at the population or eco-
logic level: aggregate, environmental, and
global variables (28). Aggregate variables are
summaries of variables originally measured
at the individual level, such as average
income or proportion of smokers. Environ-
mental variables are physical characteristics
of the place in which members of each group
live. Environmental epidemiology focuses
mostly on such variables. Many environ-
mental exposures are so universal—such as
exposure through community water supply
(29) or long-term average exposure to air
pollution (30) or hours of sunlight expo-
sure—that measurements done at the com-
munity level give a fair approximation of the
exposure at the individual level. In such situ-
ations, studies comparing individuals will
not achieve sufficient contrast in exposure,
so comparisons among populations are
needed. Global variables are characteristics
of groups, organizations, or ecosystems—
e.g., herd immunity to infections produced
by vaccination or the existence of a speciﬁc
law—that have no analogue at the individual
level, unlike the aggregate and environmen-
tal variables. Global variables can be studied
only at the population level.
Population-level studies include purely
ecologic studies (in which the unit of investi-
gation is the population rather than the indi-
vidual), but also include studies involving a
mix of population-, individual-, and micro-
level analyses (31). Ecologic variables can
affect individual health either directly or
through some known individual-level charac-
teristics or they can modify the effect of the
individual-level risk factors (32). An example
of such effect modification is the effect of
arsenic on cancer risk, where results from one
population, in this case Taiwan, may not be
generalizable to other countries due to differ-
ences in metabolism or diet (33). To separate
these effects we need to collect data both at
the population and the individual level, and
possibly also at the micro-level. This can be
done using a two-stage design, where detailed
individual-level information is collected at
least from subsamples of the populations (34).
This has been done in epidemiologic studies
on the effects on mortality of long-term
exposure to air pollution, where air pollution
exposure has been measured at the popula-
tion level, but detailed data on lifestyle and
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vidual level (30).
A variant of the pure ecologic studies is
the time–series studies, which have produced
major breakthroughs in air pollution epi-
demiology (30). In this design, data are
aggregated over time, not over area as in
most ecologic designs, and the association
between daily average levels of air pollution
and daily average mortality or morbidity in
the area is then analyzed. Because the same
population is being compared over time,
only variables that change from day to day in
parallel with the air pollution levels can
confound the association between air pollu-
tion and mortality. Therefore, as most indi-
vidual-level risk factors are not confounders
and the numbers involved are very large,
time–series analyses can detect very small rel-
ative risks (35). Time–series studies can also
be done at the individual level by, for exam-
ple, following up a panel of asthmatics with
daily measurements of symptoms and lung
function (30). In panel studies, exposure is
usually measured at the population level by a
centrally located monitor, but can be supple-
mented by measurements of personal expo-
sure (36). Panel studies can be analyzed by
aggregating the data over time or by multi-
level modeling simultaneously considering
the individual and the group level.
In addition to these scientiﬁc issues rele-
vant to risk assessment, consideration of the
population context is particularly important
in studies intended for risk management,
such as local ﬁeld investigations. In these sit-
uations, researchers tend to narrow down the
study and focus on a speciﬁc substance and a
single “hard” end point, such as cancer,
whereas the main concerns of the public may
be broader, including issues such as noise,
annoyance, or decrease in property values.
Negative findings from studies of narrowly
deﬁned exposures and end points, done with-
out insufficient power, are easily misinter-
preted to mean there is “no risk” in general.
On the other hand, positive results from a
study often invite more studies because one
study is not considered sufﬁcient to establish
causality (37). Therefore, it is important to
start from the problem at hand and not let
the methods determine the problem. Guide-
lines for community participation are also
required (10) and it is important to be
explicit on the limitations of epidemiologic
studies (37). This does not mean that studies
should not be done of speciﬁc exposures and
end points, but rather that these cannot sub-
stitute for investigating and acting on broader
issues of community concern.
Ecosystem Level 
Besides considering the direct human health
effects of environmental exposures, it is also
important to consider the long-term and
indirect threats to human health from the
disruption of the local, regional, and global
ecosystems (8,11). This requires develop-
ment of new methodologies, such as a sys-
tems-based approach, that are quite different
from the usual epidemiologic techniques and
always require interdisciplinary collabora-
tions. Several such interdisciplinary initia-
tives have been made recently with regard to
the concept of ecosystem health, which
attempts to integrate the biophysical, soci-
etal, economic, and human health dimen-
sions of ecosystems (38). 
The challenge of ecosystem-level analyses
is to incorporate evidence from several ﬁelds
of research into one assessment. Chan et al.
(39) have proposed an integrated assessment
framework on the effect of global climatic
change on the spread on infectious diseases,
which is one of the most cited health effects
of climatic change. The framework is com-
posed of the effects of the predicted climatic
change on the vectors and pathogens, on
ecology, and on the society. These changes
and their interconnections in turn produce
changes in human physiology and morbid-
ity. Such frameworks allow identiﬁcation of
potentially important research gaps and a
better understanding of the whole system.
One approach to combining evidence
from several fields is mathematical model-
ing. One of the ﬁrst truly integrative models
analyzes the effect of different climatic sce-
narios on the future risk of malaria (40).
The model is based on estimated transmis-
sion potential of malaria, which was mod-
eled as a function of the human-biting rate
of the mosquitoes, human susceptibility,
mosquito susceptibility, daily survival prob-
ability of the mosquito, and incubation
period of the parasite inside the mosquito
(40). All but the last of these depend on the
mosquito species and three out of five
depend on temperature. As mosquitoes
breed on standing water, a minimum level
of rainfall is also required. For simplicity,
the model was estimated only for the 18
main species of mosquitoes and only for
Plasmodium vivax and P. falciparum; the
current world distribution of mosquitoes
was assumed to stay constant. Combining
this information with scenarios of future
population growth suggests that in 2080 an
estimated 450 million additional people are
at risk of malaria due to climatic change.
A more direct application of the usual
epidemiologic approach to the global level is
the predicted effect of the changes in global
fossil fuel combustion on levels of outdoor
particulate air pollution, which in turn have
been associated with increased mortality and
morbidity (41). The model uses information
on projected changes in CO2 emissions and
the use of different fossil-fuels in four sec-
tors, i.e., electric utility, residential/com-
mercial, industrial, and transportation, in
nine global regions. Future levels of particu-
late air pollution are estimated based on
large-scale air-dispersion models developed
for the United States. Estimated long-term
average levels of particulate air pollution, in
combination with the estimated sizes of the
populations at risk, was then used to esti-
mate number of premature deaths based on
estimates from epidemiologic studies.
According to this model, an estimated 8
million avoidable deaths would occur
between 2000 and 2020 under the business-
as-usual scenario, when compared with the
climate-policy scenario.
Integrating evidence from several fields
of research can be an extremely complex
task. However, few alternatives are appropri-
ate to tackle the long-term health effects of
ecosystem change. Epidemiologists obviously
are key members in working groups doing
such integrative assessments and modeling
efforts. In addition, new empirical studies
are also needed on the links between health
and climatic condition (39), such as the
studies on the health effects of the El Niño
oscillation (42), which resemble future cli-
matic changes. 
Conclusions
With increasing emphasis on individual
exposures and susceptibility and on mecha-
nisms, environmental epidemiologists risk
losing their population perspective of disease
causation and prevention. This shift has par-
alleled the developments in epidemiologic
research in general (4,5). In environmental
epidemiology, where many of the expo-
sure–disease associations are weak, well-con-
ducted individual-level studies have in many
situations been important to establish more
firmly the causal associations between spe-
cific exposures and specific diseases (24).
However, individual- and micro-level analy-
ses will not be able to address many of the
most important challenges that environmen-
tal epidemiology currently faces, and can
lead to a poor choice of hypotheses, poor
research, and poor risk management. 
An excessive focus on the individual or
the micro-level can lead us to focus our
research on hypotheses generated at these
levels and not on the main environmental
health problems. In addition, many relevant
environmental exposures are practically uni-
versal or are characteristics of the population,
not the individual, so they can be studied
only by comparing populations rather than
individuals. The involuntary nature of most
environmental exposures and the multitude
of outcomes, both health- and nonhealth-
related, also necessitates consideration of the
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and values of the exposed population (10).
Finally, the human impact of local and
global ecosystems and the ultimate depen-
dence of humans on ecosystems requires us
to study the indirect and long-term effects
on environmental decisions (17,43).
Therefore, it is important not to focus
only on the individual level, but to conduct
environmental epidemiology studies at the
appropriate level or levels for the problem
under consideration. Although ecologic stud-
ies have been criticized, they can produce
important results. This has recently been
shown by studies on the international differ-
ences in the prevalence of asthma (27), which
have revolutionized our thinking about
asthma and by the time–series studies, which
have done the same with regard to ambient air
pollution (30). Therefore, there is a clear need
to develop better methods for population-level
and ecosystem-level studies in parallel with
development of better methods for individual-
level studies (23). We also need better meth-
ods for combining information from
different levels, such as combining individual
and population levels in multilevel analyses
(44) or through study of gene-environment
interactions. The task becomes even more
challenging when the ecosystem level is also
considered, and the first steps in this task
have already been taken (39–41). The com-
plexity of the problems requires multidiscipli-
nary collaboration of epidemiologists not
only with toxicology, environmental hygiene,
and medicine, but also with ecology, social
sciences, meteorology, and systems analysis,
and with other scientists.
A good example is research on health
effects of particulate air pollution, which has
included intensive epidemiologic studies on
the individual level, time–series studies, and
population comparisons together with toxico-
logic research (30). Recently, scientists have
also recognized that both particulate pollution
and the most important causes of climatic
warming are produced by the same process—
burning of fossil fuels (41). Therefore, the
solution to the problem with particulate pol-
lution in the long run cannot focus solely on
reducing the particulate emissions by techni-
cal means; it is also important to convert away
from burning of fossil fuel. This emphasizes
the need to consider all possible short- and-
long term effects of environment emissions at
all levels: molecular, individual, population,
and ecosystem.
In conclusion, the main environmental
health problems must be deﬁned at the pop-
ulation and ecosystem levels, instead of
allowing the available research methodology
to define the problems that are considered
most appropriate for study. Better research
and development of new research methods is
needed at all levels, from the molecular to
the ecosystem level, but it is crucially impor-
tant to choose the most appropriate level or
levels of research for a particular environ-
mental problem. The different levels should,
however, not be considered competitive, but
rather complementary (45). Only by consid-
ering all of these levels and by developing
further our methods to combine evidence
from these different levels can we hope to
respond satisfactorily to the challenges facing
environmental epidemiology today.
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